phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

Target id: 2153

Nomenclature: phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

Abbreviated Name: PI3Kα

Family: Phosphatidylinositol-4,5-bisphosphate 3-kinase family, Phosphatidylinositol kinases

Annotation status:  image of an orange circle Annotated and awaiting review. Please contact us if you can help with reviewing.  » Email us

   GtoImmuPdb view: OFF :     phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha has curated GtoImmuPdb data

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 1068 3q26.3 PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
Mouse - 1068 3 B Pik3ca phosphatidylinositol-4
Rat - 1068 2 q25 Pik3ca phosphatidylinositol-4
Previous and Unofficial Names
PI3K | caPI3K | PI3Kalpha | PtdIns-3-kinase subunit alpha | p110α/PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | phosphatidylinositol-4
Database Links
BRENDA
CATH/Gene3D
Ensembl Gene
Entrez Gene
GenitoUrinary Development Molecular Anatomy Project
Human Protein Atlas
KEGG Enzyme
KEGG Gene
OMIM
Orphanet
RefSeq Nucleotide
RefSeq Protein
SynPHARM
UniProtKB
Wikipedia
Selected 3D Structures
Image of receptor 3D structure from RCSB PDB
Description:  Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3Kalpha
PDB Id:  3ZIM
Resolution:  2.85Å
Species:  Human
References:  33
Image of receptor 3D structure from RCSB PDB
Description:  Solution structure of the C2 domain from human PI3-kinase p110 subunit alpha
PDB Id:  2ENQ
Resolution:  0.0Å
Species:  Human
References: 
Enzyme Reaction
EC Number: 2.7.1.153
EC Number: 2.7.11.1

Download all structure-activity data for this target as a CSV file

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
bimiralisib Hs Inhibition 8.8 pKd
pKd 8.8 (Kd 1.5x10-9 M)
IPI549 Hs Inhibition 7.8 pKd 16
pKd 7.8 (Kd 1.7x10-8 M) [16]
quinostatin Hs Inhibition 6.2 pKd 46
pKd 6.2 (Kd 6x10-7 M) [46]
Description: In vitro binding affinity to recombinant complex of PI3K alpha regulatory and catalytic subunits.
GDC-0077 Hs Inhibition 10.5 pKi 4
pKi 10.5 (Ki 3.4x10-11 M) [4]
taselisib Hs Inhibition 9.5 – 10.1 pKi 4,34
pKi 10.1 (Ki 9x10-11 M) [4]
pKi 9.5 (Ki 2.9x10-10 M) [34]
PF-04691502 Hs Inhibition 9.2 pKi 30
pKi 9.2 (Ki 5.7x10-10 M) [30]
compound 82 [PMID: 21332118] Hs Inhibition 8.9 pKi 13
pKi 8.9 (Ki 1.2x10-9 M) [13]
pictilisib Hs Inhibition 8.6 pKi 4
pKi 8.6 (Ki 2.56x10-9 M) [4]
omipalisib Hs Inhibition 7.7 pKi 27
pKi 7.7 (Ki 1.9x10-8 M) [27]
wortmannin Hs Inhibition 6.9 pKi 21
pKi 6.9 (Ki 1.2x10-7 M) [21]
gedatolisib Hs Inhibition 9.4 pIC50 42
pIC50 9.4 (IC50 4x10-10 M) [42]
HS-173 Hs Inhibition 9.1 pIC50 26
pIC50 9.1 (IC50 8x10-10 M) [26]
PIK-75 Hs Inhibition 8.2 – 9.5 pIC50 24,28
pIC50 9.5 (IC50 3x10-10 M) [24]
pIC50 8.2 (IC50 5.8x10-9 M) [28]
PI-103 Hs Inhibition 8.7 pIC50 39
pIC50 8.7 (IC50 2x10-9 M) [39]
pictilisib Hs Inhibition 8.5 pIC50 17
pIC50 8.5 (IC50 3x10-9 M) [17]
dactolisib Hs Inhibition 8.4 pIC50 31
pIC50 8.4 (IC50 4x10-9 M) [31]
BGT-226 Hs Inhibition 8.4 pIC50 32
pIC50 8.4 (IC50 4x10-9 M) [32]
KU-0060648 Hs Inhibition 8.4 pIC50 7
pIC50 8.4 (IC50 4x10-9 M) [7]
apitolisib Hs Inhibition 8.3 pIC50 41
pIC50 8.3 (IC50 4.8x10-9 M) [41]
alpelisib Hs Inhibition 8.3 pIC50 19
pIC50 8.3 (IC50 5x10-9 M) [19]
AZD8835 Hs Inhibition 8.2 pIC50 3
pIC50 8.2 (IC50 6.2x10-9 M) [3]
LY3023414 Hs Inhibition 8.2 pIC50 2
pIC50 8.2 (IC50 6.1x10-9 M) [2]
CH5132799 Hs Inhibition 7.8 pIC50 36
pIC50 7.8 (IC50 1.4x10-8 M) [36]
ZSTK474 Hs Inhibition 7.8 pIC50 45
pIC50 7.8 (IC50 1.6x10-8 M) [45]
VS-5584 Hs Inhibition 7.8 pIC50 23
pIC50 7.8 (IC50 1.6x10-8 M) [23]
CUDC-907 Hs Inhibition 7.7 pIC50 38
pIC50 7.7 (IC50 1.9x10-8 M) [38]
buparlisib Hs Inhibition 7.5 pIC50 5
pIC50 7.5 (IC50 3x10-8 M) [5]
AZD8186 Hs Inhibition 7.5 pIC50 22
pIC50 7.5 (IC50 3.5x10-8 M) [22]
pilaralisib Hs Inhibition 7.4 pIC50 45
pIC50 7.4 (IC50 3.9x10-8 M) [45]
PP121 Hs Inhibition 7.3 pIC50 1
pIC50 7.3 (IC50 5.2x10-8 M) [1]
PI 3-Kg inhibitor Hs Inhibition 7.2 pIC50 6
pIC50 7.2 (IC50 6x10-8 M) [6]
compound 11j [PMID: 23021994] Hs Inhibition 7.0 pIC50 20
pIC50 7.0 (IC50 9.2x10-8 M) [20]
serabelisib Hs Inhibition >7.0 pIC50 40
pIC50 >7.0 (IC50 <1x10-7 M) [40]
LY 294002 Hs Inhibition 6.7 pIC50 7,10
pIC50 6.7 (IC50 3x10-7 – 2x10-7 M) [7,10]
INK-128 Hs Inhibition 6.7 pIC50 25
pIC50 6.7 (IC50 2.19x10-7 M) [25]
leniolisib Hs Inhibition 6.6 pIC50 11
pIC50 6.6 (IC50 2.62x10-7 M) [11]
Description: In vitro enzyme assay
idelalisib Hs Inhibition 6.1 pIC50 29
pIC50 6.1 (IC50 8.2x10-7 M) [29]
AZD6482 Hs Inhibition 6.1 pIC50 35
pIC50 6.1 (IC50 8.7x10-7 M) [35]
eCF309 Hs Inhibition 6.0 pIC50 18
pIC50 6.0 (IC50 9.81x10-7 M) [18]
Description: In a biochemical assay.
TG-100-115 Hs Inhibition 5.9 pIC50 37
pIC50 5.9 (IC50 1.3x10-6 M) [37]
compound 28 [PMID: 24387221] Hs Inhibition 5.8 pIC50 8
pIC50 5.8 (IC50 1.539x10-6 M) [8]
duvelisib Hs Inhibition 5.8 pIC50 43
pIC50 5.8 (IC50 1.602x10-6 M) [43]
PI 3-Kg inhibitor II Hs Inhibition 5.3 pIC50 6
pIC50 5.3 (IC50 4.5x10-6 M) [6]
nemiralisib Hs Inhibition 5.3 pIC50 15
pIC50 5.3 (IC50 5.011x10-6 M) [15]
Description: In a homogeneous time-resolved fluorescence (HTRF) assay
quinostatin Hs Inhibition 4.8 pIC50 46
pIC50 4.8 (IC50 1.5x10-5 M) [46]
Description: Inhibition of lipid-kinase activity in vitro.
AMG319 Hs Inhibition 4.5 pIC50 12
pIC50 4.5 (IC50 3.3x10-5 M) [12]
Allosteric Modulators
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
PIK-108 Hs Negative <5.0 pIC50 9
pIC50 <5.0 (IC50 >1x10-5 M) [9]
DiscoveRx KINOMEscan® screen
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan
Reference: 14,44

Key to terms and symbols Click column headers to sort
Target used in screen: PIK3CA
Ligand Sp. Type Action Affinity Units
pictilisib Hs Inhibitor Inhibition 9.0 pKd
PI-103 Hs Inhibitor Inhibition 8.8 pKd
TG-100-115 Hs Inhibitor Inhibition 7.2 pKd
PP-242 Hs Inhibitor Inhibition 6.8 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
SB203580 Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
GSK690693 Hs Inhibitor Inhibition <5.5 pKd
masitinib Hs Inhibitor Inhibition <5.5 pKd
A-674563 Hs Inhibitor Inhibition <5.5 pKd
Target used in screen: PIK3CA(C420R)
Ligand Sp. Type Action Affinity Units
PI-103 Hs Inhibitor Inhibition 8.9 pKd
pictilisib Hs Inhibitor Inhibition 8.8 pKd
TG-100-115 Hs Inhibitor Inhibition 7.0 pKd
PP-242 Hs Inhibitor Inhibition 6.7 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
SB203580 Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
GSK690693 Hs Inhibitor Inhibition <5.5 pKd
masitinib Hs Inhibitor Inhibition <5.5 pKd
A-674563 Hs Inhibitor Inhibition <5.5 pKd
Target used in screen: PIK3CA(E542K)
Ligand Sp. Type Action Affinity Units
PI-103 Hs Inhibitor Inhibition 8.9 pKd
pictilisib Hs Inhibitor Inhibition 8.8 pKd
TG-100-115 Hs Inhibitor Inhibition 7.1 pKd
PP-242 Hs Inhibitor Inhibition 6.7 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
SB203580 Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
GSK690693 Hs Inhibitor Inhibition <5.5 pKd
masitinib Hs Inhibitor Inhibition <5.5 pKd
A-674563 Hs Inhibitor Inhibition <5.5 pKd
Target used in screen: PIK3CA(E545A)
Ligand Sp. Type Action Affinity Units
pictilisib Hs Inhibitor Inhibition 9.1 pKd
PI-103 Hs Inhibitor Inhibition 8.8 pKd
TG-100-115 Hs Inhibitor Inhibition 7.1 pKd
PP-242 Hs Inhibitor Inhibition 6.6 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
SB203580 Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
GSK690693 Hs Inhibitor Inhibition <5.5 pKd
masitinib Hs Inhibitor Inhibition <5.5 pKd
A-674563 Hs Inhibitor Inhibition <5.5 pKd
Target used in screen: PIK3CA(E545K)
Ligand Sp. Type Action Affinity Units
pictilisib Hs Inhibitor Inhibition 8.9 pKd
PI-103 Hs Inhibitor Inhibition 8.8 pKd
TG-100-115 Hs Inhibitor Inhibition 7.1 pKd
PP-242 Hs Inhibitor Inhibition 6.7 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
SB203580 Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
GSK690693 Hs Inhibitor Inhibition <5.5 pKd
masitinib Hs Inhibitor Inhibition <5.5 pKd
A-674563 Hs Inhibitor Inhibition <5.5 pKd
Target used in screen: PIK3CA(H1047L)
Ligand Sp. Type Action Affinity Units
PI-103 Hs Inhibitor Inhibition 8.5 pKd
pictilisib Hs Inhibitor Inhibition 8.4 pKd
lestaurtinib Hs Inhibitor Inhibition 7.3 pKd
TG-100-115 Hs Inhibitor Inhibition 6.5 pKd
PP-242 Hs Inhibitor Inhibition 6.4 pKd
staurosporine Hs Inhibitor Inhibition 6.4 pKd
midostaurin Hs Inhibitor Inhibition 6.0 pKd
SB203580 Hs Inhibitor Inhibition <5.5 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
Target used in screen: PIK3CA(H1047Y)
Ligand Sp. Type Action Affinity Units
PI-103 Hs Inhibitor Inhibition 8.5 pKd
pictilisib Hs Inhibitor Inhibition 8.4 pKd
TG-100-115 Hs Inhibitor Inhibition 6.8 pKd
PP-242 Hs Inhibitor Inhibition 6.4 pKd
lestaurtinib Hs Inhibitor Inhibition 6.2 pKd
SB203580 Hs Inhibitor Inhibition <5.5 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
GSK690693 Hs Inhibitor Inhibition <5.5 pKd
masitinib Hs Inhibitor Inhibition <5.5 pKd
Target used in screen: PIK3CA(I800L)
Ligand Sp. Type Action Affinity Units
PI-103 Hs Inhibitor Inhibition 8.5 pKd
pictilisib Hs Inhibitor Inhibition 8.1 pKd
TG-100-115 Hs Inhibitor Inhibition 6.8 pKd
PP-242 Hs Inhibitor Inhibition 6.7 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
SB203580 Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
GSK690693 Hs Inhibitor Inhibition <5.5 pKd
masitinib Hs Inhibitor Inhibition <5.5 pKd
A-674563 Hs Inhibitor Inhibition <5.5 pKd
Target used in screen: PIK3CA(M1043I)
Ligand Sp. Type Action Affinity Units
PI-103 Hs Inhibitor Inhibition 8.5 pKd
pictilisib Hs Inhibitor Inhibition 8.4 pKd
TG-100-115 Hs Inhibitor Inhibition 6.5 pKd
PP-242 Hs Inhibitor Inhibition 6.4 pKd
lestaurtinib Hs Inhibitor Inhibition 6.0 pKd
SB203580 Hs Inhibitor Inhibition <5.5 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
GSK690693 Hs Inhibitor Inhibition <5.5 pKd
masitinib Hs Inhibitor Inhibition <5.5 pKd
Target used in screen: PIK3CA(Q546K)
Ligand Sp. Type Action Affinity Units
PI-103 Hs Inhibitor Inhibition 8.8 pKd
pictilisib Hs Inhibitor Inhibition 8.8 pKd
TG-100-115 Hs Inhibitor Inhibition 7.1 pKd
PP-242 Hs Inhibitor Inhibition 6.8 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
SB203580 Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
GSK690693 Hs Inhibitor Inhibition <5.5 pKd
masitinib Hs Inhibitor Inhibition <5.5 pKd
A-674563 Hs Inhibitor Inhibition <5.5 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »
Immunopharmacology Comments
PI3Kα is priomarily recognised for its oncogenic function. We have included it in GtoImmuPdb based on its numerous GO immune process associations.
Immuno Process Associations
Immuno Process:  Inflammation
Immuno Process ID:  2
Comment: 
GO Annotation:  Associated to GO processes
GO Processes:  inflammatory response (GO:0006954) IBA
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) TAS
innate immune response (GO:0045087) IBA
leukocyte migration (GO:0050900) TAS
References: 
Immuno Process:  Cytokine production & signalling
Immuno Process ID:  9
Comment: 
GO Annotation:  Associated to GO processes
GO Processes:  interleukin-7-mediated signaling pathway (GO:0038111) TAS
References: 
Immuno Process:  Antigen presentation
Immuno Process ID:  3
Comment: 
GO Annotation:  Associated to GO processes
GO Processes:  Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) TAS
References: 
Immuno Process:  T cell (activation)
Immuno Process ID:  4
Comment: 
GO Annotation:  Associated to GO processes
GO Processes:  adaptive immune response (GO:0002250) IBA
T cell costimulation (GO:0031295) TAS
References: 
Immuno Process:  B cell (activation)
Immuno Process ID:  5
Comment: 
GO Annotation:  Associated to GO processes
GO Processes:  adaptive immune response (GO:0002250) IBA
References: 
Immuno Process:  Immune regulation
Immuno Process ID:  6
Comment: 
GO Annotation:  Associated to GO processes
GO Processes:  T cell costimulation (GO:0031295) TAS
Fc-epsilon receptor signaling pathway (GO:0038095) TAS
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) TAS
T cell receptor signaling pathway (GO:0050852) TAS
References: 
Immuno Process:  Chemotaxis & migration
Immuno Process ID:  10
Comment: 
GO Annotation:  Associated to GO processes
GO Processes:  T cell costimulation (GO:0031295) TAS
leukocyte migration (GO:0050900) TAS
References: 
Immuno Process:  Cellular signalling
Immuno Process ID:  11
Comment: 
GO Annotation:  Associated to GO processes
GO Processes:  T cell costimulation (GO:0031295) TAS
Fc-epsilon receptor signaling pathway (GO:0038095) TAS
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) TAS
T cell receptor signaling pathway (GO:0050852) TAS
References: 
Clinically-Relevant Mutations and Pathophysiology
Disease:  Breast cancer
Disease Ontology: DOID:1612
OMIM: 114480
Disease:  Colorectal cancer
Disease Ontology: DOID:9256
OMIM: 114500
Disease:  Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi
Synonyms: CLOVE syndrome [Orphanet: ORPHA140944]
OMIM: 612918
Orphanet: ORPHA140944
Disease:  Cowden syndrome 5; CWS5
Synonyms: Cowden disease [Disease Ontology: DOID:6457]
Cowden syndrome [Orphanet: ORPHA201]
Disease Ontology: DOID:6457
OMIM: 615108
Orphanet: ORPHA201
Disease:  Hemimegalencephaly
Orphanet: ORPHA99802
Disease:  Hepatocellular carcinoma
Disease Ontology: DOID:684
OMIM: 114550
Disease:  Hereditary nonpolyposis colon cancer
Orphanet: ORPHA144
Disease:  Keratosis, seborrheic
Synonyms: Seborrheic keratosis [Disease Ontology: DOID:6498]
Disease Ontology: DOID:6498
OMIM: 182000